Effect of a seven-strain probiotic on dietary intake, inflammatory markers, and T-cells in severe traumatic brain injury patients: A randomized, double-blind, placebo-controlled trial
Science Progress · 2024
DOI: 10.1177/00368504241259299 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Science Progress, 2024. Verfasst von Seyed Hamze Abbaszadeh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Diet Therapy, School of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Probiotics, Brain Injuries, Traumatic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Inflammatory processes are key factors in pathological events associated with severe traumatic brain injury (STBI). The aim of this trial was to determine the effect of probiotics on anthropometric measures, disease severity, inflammatory markers, and T cells in patients with STBI.
Methods
Forty adult patients with STBI were enrolled in this parallel randomized, double-blind, placebo-controlled trial. Energy and protein status, Acute Physiology and Chronic Health Evaluation (APACHE II) score, Sequential Organ Failure Assessment (SOFA), interleukin 10 (IL-10), interleukin 1β (IL-1β), tumor necrosis factor-alpha (TNF-α), transforming growth factor beta (TGF-β), T-helper 17 (Th17), and T- Regulator (T-reg) cells were assessed at baseline (day 1), and week 2 (day 14) for each patient.
Results
Probiotic supplementation led to a substantial reduction in the serum levels of TNF-α (from 10.15 ± 6.52 to 5.05 ± 3.27) ( P = 0.034), IL-1β (from 11.84 ± 7.74 to 5.87 ± 3.77) ( P < 0.001), and Th17 cells (from 5.19 ± 1.69 to 2.67 ± 1.89) ( P < 0.001) and a substantial increase in the serum levels of IL-10 (from 3.35 ± 1.45 to 6.17 ± 2.04) ( P = 0.038), TGF-β (from 30.5 ± 15.27 to 46.25 ± 21.05) ( P < 0.001), and T-reg cells (from 2.83 ± 1.43 to 4.29 ± 1.89) ( P < 0.001) compared with the placebo group. Furthermore, no notable changes were observed in energy and protein intake and also, terms of SOFA and APACHE II scores following probiotic treatment compared with the placebo.
Conclusions
Probiotics could reduce inflammation and improve cellular immunity and may be considered as an adjunctive therapy in STBI patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Diet Therapy, School of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
- Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Anesthesiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Seyed Hamze Abbaszadeh
Zitieren
APA
Abbaszadeh, S. H., Yousefi, M., Arefhosseini, S. R., Mahmoodpoor, A., & Mameghani, M. E. (2024). Effect of a seven-strain probiotic on dietary intake, inflammatory markers, and T-cells in severe traumatic brain injury patients: A randomized, double-blind, placebo-controlled trial. Science Progress. https://doi.org/10.1177/00368504241259299
Vancouver
Abbaszadeh SH, Yousefi M, Arefhosseini SR, Mahmoodpoor A, Mameghani ME. Effect of a seven-strain probiotic on dietary intake, inflammatory markers, and T-cells in severe traumatic brain injury patients: A randomized, double-blind, placebo-controlled trial. Science Progress. 2024. doi:10.1177/00368504241259299
BibTeX
@article{Abbaszadeh2024,
author = {Abbaszadeh, Seyed Hamze and Yousefi, Mehdi and Arefhosseini, Seyed Rafie and Mahmoodpoor, Ata and Mameghani, Mehrangiz Ebrahimi},
title = {Effect of a seven-strain probiotic on dietary intake, inflammatory markers, and T-cells in severe traumatic brain injury patients: A randomized, double-blind, placebo-controlled trial},
journal = {Science Progress},
year = {2024},
doi = {10.1177/00368504241259299}
}
EUVIMED